Christopher Manz
Overview
Explore the profile of Christopher Manz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
111
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Healey T, Dayanim G, Streltzov N, Kane K, Manz C, Williams S, et al.
J Correct Health Care
. 2025 Jan;
31(1):62-69.
PMID: 39752180
Limited data exist on cancer screening in carceral facilities. This study evaluates the feasibility and outcomes of a population-based lung cancer screening initiative in a carceral setting. This is a...
2.
3.
Ramaswamy M, Manz C, Kouyoumdjian F, Vest N, Puglisi L, Wang E, et al.
J Natl Cancer Inst
. 2023 May;
115(10):1128-1131.
PMID: 37219371
The cancer disparities between people with incarceration histories compared with those who do not have those histories are vast. Opportunities for bolstering cancer equity among those impacted by mass incarceration...
4.
Huffman B, Basu Mallick A, Horick N, Wang-Gillam A, Hosein P, Morse M, et al.
JAMA Netw Open
. 2023 Jan;
6(1):e2249720.
PMID: 36602796
Importance: Treatment options are limited for patients with advanced pancreatic ductal adenocarcinoma (PDAC) beyond first-line 5-fluorouracil, leucovorin, irinotecan, and oxaliplatin (FOLFIRINOX), with such individuals commonly being treated with gemcitabine and...
5.
Stavrou E, Qiu J, Zafar A, Tramontano A, Isakoff S, Winer E, et al.
JCO Oncol Pract
. 2022 Jun;
18(9):e1447-e1453.
PMID: 35671420
Purpose: The COVID-19 pandemic forced rapid adoption of telemedicine (TM) for breast oncology visits in the United States, but the appropriate role of postpandemic TM is uncertain. We sought to...
6.
Li E, Manz C, Liu M, Chen J, Chivers C, Braun J, et al.
PLoS One
. 2022 May;
17(5):e0267012.
PMID: 35622812
Background: While health systems have implemented multifaceted interventions to improve physician and patient communication in serious illnesses such as cancer, clinicians vary in their response to these initiatives. In this...
7.
Parikh R, Manz C, Chivers C, Regli S, Braun J, Draugelis M, et al.
JAMA Netw Open
. 2019 Oct;
2(10):e1915997.
PMID: 31651973
Importance: Machine learning algorithms could identify patients with cancer who are at risk of short-term mortality. However, it is unclear how different machine learning algorithms compare and whether they could...
8.
Manz C, Rendle K, Bekelman J
BMJ Qual Saf
. 2019 Aug;
29(2):91-94.
PMID: 31444236
No abstract available.
9.
Manz C, Ross J, Grande D
N Engl J Med
. 2014 Nov;
371(20):1857-9.
PMID: 25390738
Pharmaceutical marketing can lead to overdiagnosis, overtreatment, and overuse of medications. Digital advertising creates new pathways for reaching physicians, allowing delivery of marketing messages at the point of care, when...